Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Nexontm neurotechnology platform?a major advancement in understanding human brain function. The platform integrates tissue engineering, neural interfacing and AI to engineer human brains at-scale and ...

ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology ...

Ascletis Pharma Inc. announced that it will present poster presentations on its investigational drugs, ASC30 and ASC47, at the 85th Scientific Sessions of the American Diabetes As ...